Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.7 EUR | +1.11% |
|
-0.92% | -2.70% |
07-01 | US FDA Approves Formycon's Biosimilar to Treat Serious Retinal Diseases | MT |
06-18 | Borse Frankfurt-News: Many winners and many losers (second-line stocks) | DP |
MarketScreener Editorial Features
Novartis AG : Sandoz takes its first steps on the stock exchange | October 04, 2023 at 03:32 pm |
- Stock Market
- Equities
- FYB Stock
- FYB Stock
- News Formycon AG
- MarketScreener Editorial Features